Selected research
Industry Research
Polycystic Ovary Syndrome (PCOS) Blood Test Industry Research Report 2026
Market perspective
The global Polycystic Ovary Syndrome (PCOS) Blood Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Polycystic Ovary Syndrome (PCOS) Blood Test market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Polycystic Ovary Syndrome (PCOS) Blood Test market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Polycystic Ovary Syndrome (PCOS) Blood Test market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Polycystic Ovary Syndrome (PCOS) Blood Test include Goodbody, MyHealth Checked, Randox Health, BioSure, Forth, Medichecks, LetsGet Checked, Thriva and MyDiagnostics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Polycystic Ovary Syndrome (PCOS) Blood Test market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Polycystic Ovary Syndrome (PCOS) Blood Test.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Polycystic Ovary Syndrome (PCOS) Blood Test Market by Company
Goodbody
MyHealth Checked
Randox Health
BioSure
Forth
Medichecks
LetsGet Checked
Thriva
MyDiagnostics
ZAVA
Living Room Health
UniClinic
Polycystic Ovary Syndrome (PCOS) Blood Test Segment by Type
Fingerstick Blood
Venous Blood
Polycystic Ovary Syndrome (PCOS) Blood Test Segment by Application
Domestic
Commercial
Polycystic Ovary Syndrome (PCOS) Blood Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polycystic Ovary Syndrome (PCOS) Blood Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polycystic Ovary Syndrome (PCOS) Blood Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polycystic Ovary Syndrome (PCOS) Blood Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Polycystic Ovary Syndrome (PCOS) Blood Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fingerstick Blood
- Venous Blood
Applications
- Domestic
- Commercial
Companies covered
- Goodbody
- MyHealth Checked
- Randox Health
- BioSure
- Forth
- Medichecks
- LetsGet Checked
- Thriva
- MyDiagnostics
- ZAVA
- Living Room Health
- UniClinic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Polycystic Ovary Syndrome (PCOS) Blood Test by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Fingerstick Blood
- 2.2.3 Venous Blood
- 2.3 Polycystic Ovary Syndrome (PCOS) Blood Test by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Domestic
- 2.3.3 Commercial
- 2.4 Assumptions and Limitations
3 Polycystic Ovary Syndrome (PCOS) Blood Test Breakdown Data by Type
- 3.1 Global Polycystic Ovary Syndrome (PCOS) Blood Test Historic Market Size by Type (2021-2026)
- 3.2 Global Polycystic Ovary Syndrome (PCOS) Blood Test Forecasted Market Size by Type (2027-2032)
4 Polycystic Ovary Syndrome (PCOS) Blood Test Breakdown Data by Application
- 4.1 Global Polycystic Ovary Syndrome (PCOS) Blood Test Historic Market Size by Application (2021-2026)
- 4.2 Global Polycystic Ovary Syndrome (PCOS) Blood Test Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Polycystic Ovary Syndrome (PCOS) Blood Test Market Perspective (2021-2032)
- 5.2 Global Polycystic Ovary Syndrome (PCOS) Blood Test Growth Trends by Region
- 5.2.1 Global Polycystic Ovary Syndrome (PCOS) Blood Test Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Polycystic Ovary Syndrome (PCOS) Blood Test Historic Market Size by Region (2021-2026)
- 5.2.3 Polycystic Ovary Syndrome (PCOS) Blood Test Forecasted Market Size by Region (2027-2032)
- 5.3 Polycystic Ovary Syndrome (PCOS) Blood Test Market Dynamics
- 5.3.1 Polycystic Ovary Syndrome (PCOS) Blood Test Industry Trends
- 5.3.2 Polycystic Ovary Syndrome (PCOS) Blood Test Market Drivers
- 5.3.3 Polycystic Ovary Syndrome (PCOS) Blood Test Market Challenges
- 5.3.4 Polycystic Ovary Syndrome (PCOS) Blood Test Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Polycystic Ovary Syndrome (PCOS) Blood Test Players by Revenue
- 6.1.1 Global Top Polycystic Ovary Syndrome (PCOS) Blood Test Players by Revenue (2021-2026)
- 6.1.2 Global Polycystic Ovary Syndrome (PCOS) Blood Test Revenue Market Share by Players (2021-2026)
- 6.2 Global Polycystic Ovary Syndrome (PCOS) Blood Test Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Polycystic Ovary Syndrome (PCOS) Blood Test Head Office and Area Served
- 6.4 Global Polycystic Ovary Syndrome (PCOS) Blood Test Players, Product Type & Application
- 6.5 Global Polycystic Ovary Syndrome (PCOS) Blood Test Manufacturers Established Date
- 6.6 Global Polycystic Ovary Syndrome (PCOS) Blood Test Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Polycystic Ovary Syndrome (PCOS) Blood Test Market Size (2021-2032)
- 7.2 North America Polycystic Ovary Syndrome (PCOS) Blood Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Polycystic Ovary Syndrome (PCOS) Blood Test Market Size by Country (2021-2026)
- 7.4 North America Polycystic Ovary Syndrome (PCOS) Blood Test Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Polycystic Ovary Syndrome (PCOS) Blood Test Market Size (2021-2032)
- 8.2 Europe Polycystic Ovary Syndrome (PCOS) Blood Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Polycystic Ovary Syndrome (PCOS) Blood Test Market Size by Country (2021-2026)
- 8.4 Europe Polycystic Ovary Syndrome (PCOS) Blood Test Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Polycystic Ovary Syndrome (PCOS) Blood Test Market Size (2021-2032)
- 9.2 Asia-Pacific Polycystic Ovary Syndrome (PCOS) Blood Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Polycystic Ovary Syndrome (PCOS) Blood Test Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Polycystic Ovary Syndrome (PCOS) Blood Test Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Polycystic Ovary Syndrome (PCOS) Blood Test Market Size (2021-2032)
- 10.2 South America Polycystic Ovary Syndrome (PCOS) Blood Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Polycystic Ovary Syndrome (PCOS) Blood Test Market Size by Country (2021-2026)
- 10.4 South America Polycystic Ovary Syndrome (PCOS) Blood Test Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Polycystic Ovary Syndrome (PCOS) Blood Test Market Size (2021-2032)
- 11.2 Middle East & Africa Polycystic Ovary Syndrome (PCOS) Blood Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Polycystic Ovary Syndrome (PCOS) Blood Test Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Polycystic Ovary Syndrome (PCOS) Blood Test Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Goodbody
- 12.1.1 Goodbody Company Information
- 12.1.2 Goodbody Business Overview
- 12.1.3 Goodbody Revenue in Polycystic Ovary Syndrome (PCOS) Blood Test Business (2021-2026)
- 12.1.4 Goodbody Polycystic Ovary Syndrome (PCOS) Blood Test Product Portfolio
- 12.1.5 Goodbody Recent Developments
- 12.2 MyHealth Checked
- 12.2.1 MyHealth Checked Company Information
- 12.2.2 MyHealth Checked Business Overview
- 12.2.3 MyHealth Checked Revenue in Polycystic Ovary Syndrome (PCOS) Blood Test Business (2021-2026)
- 12.2.4 MyHealth Checked Polycystic Ovary Syndrome (PCOS) Blood Test Product Portfolio
- 12.2.5 MyHealth Checked Recent Developments
- 12.3 Randox Health
- 12.3.1 Randox Health Company Information
- 12.3.2 Randox Health Business Overview
- 12.3.3 Randox Health Revenue in Polycystic Ovary Syndrome (PCOS) Blood Test Business (2021-2026)
- 12.3.4 Randox Health Polycystic Ovary Syndrome (PCOS) Blood Test Product Portfolio
- 12.3.5 Randox Health Recent Developments
- 12.4 BioSure
- 12.4.1 BioSure Company Information
- 12.4.2 BioSure Business Overview
- 12.4.3 BioSure Revenue in Polycystic Ovary Syndrome (PCOS) Blood Test Business (2021-2026)
- 12.4.4 BioSure Polycystic Ovary Syndrome (PCOS) Blood Test Product Portfolio
- 12.4.5 BioSure Recent Developments
- 12.5 Forth
- 12.5.1 Forth Company Information
- 12.5.2 Forth Business Overview
- 12.5.3 Forth Revenue in Polycystic Ovary Syndrome (PCOS) Blood Test Business (2021-2026)
- 12.5.4 Forth Polycystic Ovary Syndrome (PCOS) Blood Test Product Portfolio
- 12.5.5 Forth Recent Developments
- 12.6 Medichecks
- 12.6.1 Medichecks Company Information
- 12.6.2 Medichecks Business Overview
- 12.6.3 Medichecks Revenue in Polycystic Ovary Syndrome (PCOS) Blood Test Business (2021-2026)
- 12.6.4 Medichecks Polycystic Ovary Syndrome (PCOS) Blood Test Product Portfolio
- 12.6.5 Medichecks Recent Developments
- 12.7 LetsGet Checked
- 12.7.1 LetsGet Checked Company Information
- 12.7.2 LetsGet Checked Business Overview
- 12.7.3 LetsGet Checked Revenue in Polycystic Ovary Syndrome (PCOS) Blood Test Business (2021-2026)
- 12.7.4 LetsGet Checked Polycystic Ovary Syndrome (PCOS) Blood Test Product Portfolio
- 12.7.5 LetsGet Checked Recent Developments
- 12.8 Thriva
- 12.8.1 Thriva Company Information
- 12.8.2 Thriva Business Overview
- 12.8.3 Thriva Revenue in Polycystic Ovary Syndrome (PCOS) Blood Test Business (2021-2026)
- 12.8.4 Thriva Polycystic Ovary Syndrome (PCOS) Blood Test Product Portfolio
- 12.8.5 Thriva Recent Developments
- 12.9 MyDiagnostics
- 12.9.1 MyDiagnostics Company Information
- 12.9.2 MyDiagnostics Business Overview
- 12.9.3 MyDiagnostics Revenue in Polycystic Ovary Syndrome (PCOS) Blood Test Business (2021-2026)
- 12.9.4 MyDiagnostics Polycystic Ovary Syndrome (PCOS) Blood Test Product Portfolio
- 12.9.5 MyDiagnostics Recent Developments
- 12.10 ZAVA
- 12.10.1 ZAVA Company Information
- 12.10.2 ZAVA Business Overview
- 12.10.3 ZAVA Revenue in Polycystic Ovary Syndrome (PCOS) Blood Test Business (2021-2026)
- 12.10.4 ZAVA Polycystic Ovary Syndrome (PCOS) Blood Test Product Portfolio
- 12.10.5 ZAVA Recent Developments
- 12.11 Living Room Health
- 12.11.1 Living Room Health Company Information
- 12.11.2 Living Room Health Business Overview
- 12.11.3 Living Room Health Revenue in Polycystic Ovary Syndrome (PCOS) Blood Test Business (2021-2026)
- 12.11.4 Living Room Health Polycystic Ovary Syndrome (PCOS) Blood Test Product Portfolio
- 12.11.5 Living Room Health Recent Developments
- 12.12 UniClinic
- 12.12.1 UniClinic Company Information
- 12.12.2 UniClinic Business Overview
- 12.12.3 UniClinic Revenue in Polycystic Ovary Syndrome (PCOS) Blood Test Business (2021-2026)
- 12.12.4 UniClinic Polycystic Ovary Syndrome (PCOS) Blood Test Product Portfolio
- 12.12.5 UniClinic Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst